{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:50:48Z","timestamp":1784609448070,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T00:00:00Z","timestamp":1667692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.apsb.2022.11.011","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:03:07Z","timestamp":1668038587000},"page":"1699-1710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Spatiotemporally resolved metabolomics and isotope tracing reveal CNS drug targets"],"prefix":"10.1016","volume":"13","author":[{"given":"Bo","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuechao","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingce","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Ga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6482-9991","authenticated-orcid":false,"given":"Ruiping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6545-472X","authenticated-orcid":false,"given":"Jiuming","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeper","family":"Abliz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2022.11.011_bib1","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.trechm.2019.04.009","article-title":"Challenges and opportunities in central nervous system drug discovery","volume":"1","author":"Danon","year":"2019","journal-title":"Trends Chem"},{"key":"10.1016\/j.apsb.2022.11.011_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuropharm.2016.03.021","article-title":"The need for new approaches in CNS drug discovery: why drugs have failed, and what can be done to improve outcomes","volume":"120","author":"Gribkoff","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.apsb.2022.11.011_bib3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrclinonc.2011.34","article-title":"High drug attrition rates\u2015where are we going wrong?","volume":"8","author":"Hutchinson","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.apsb.2022.11.011_bib4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev-pharmtox-010716-104624","article-title":"CNS target identification and validation: avoiding the valley of death or naive optimism?","volume":"57","author":"Hutson","year":"2017","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.apsb.2022.11.011_bib5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.31887\/DCNS.2006.8.3\/tban","article-title":"The role of serendipity in drug discovery","volume":"8","author":"Ban","year":"2006","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.apsb.2022.11.011_bib6","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.drudis.2013.07.001","article-title":"Phenotypic screens as a renewed approach for drug discovery","volume":"18","author":"Zheng","year":"2013","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2022.11.011_bib7","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00213-021-05838-3","article-title":"Challenges in CNS drug development and the role of imaging","volume":"238","author":"Howes","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.apsb.2022.11.011_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/npp.2008.166","article-title":"The role of imaging in proof of concept for CNS drug discovery and development","volume":"34","author":"Wong","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.apsb.2022.11.011_bib9","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.1021\/jm5001858","article-title":"Positron emission tomography in CNS drug discovery and drug monitoring","volume":"57","author":"Piel","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2022.11.011_bib10","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00213-019-05344-7","article-title":"The potential of 1H-MRS in CNS drug development","volume":"238","author":"Egerton","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.apsb.2022.11.011_bib11","doi-asserted-by":"crossref","first-page":"6746","DOI":"10.1021\/acs.analchem.1c00467","article-title":"Mapping metabolic networks in the brain by ambient mass spectrometry imaging and metabolomics","volume":"93","author":"Pang","year":"2021","journal-title":"Anal Chem"},{"key":"10.1016\/j.apsb.2022.11.011_bib12","article-title":"A sensitive and wide coverage ambient mass spectrometry imaging method for functional metabolites based molecular histology","volume":"5","author":"He","year":"2018","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.apsb.2022.11.011_bib13","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s41592-019-0551-3","article-title":"Comprehensive mapping of neurotransmitter networks by MALDI-MS imaging","volume":"16","author":"Shariatgorji","year":"2019","journal-title":"Nat Methods"},{"key":"10.1016\/j.apsb.2022.11.011_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe5948","article-title":"Mass spectrometry imaging identifies abnormally elevated brain l-DOPA levels and extrastriatal monoaminergic dysregulation in l-DOPA-induced dyskinesia","volume":"7","author":"Fridjonsdottir","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.apsb.2022.11.011_bib15","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1016\/j.apsb.2022.03.018","article-title":"A temporo-spatial pharmacometabolomics method to characterize pharmacokinetics and pharmacodynamics in the brain microregions by using ambient mass spectrometry imaging","volume":"12","author":"Liu","year":"2022","journal-title":"Acta Pharma Sin B"},{"key":"10.1016\/j.apsb.2022.11.011_bib16","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1038\/s41386-019-0397-5","article-title":"Molecular imaging identifies age-related attenuation of acetylcholine in retrosplenial cortex in response to acetylcholinesterase inhibition","volume":"44","author":"Vallianatou","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.apsb.2022.11.011_bib17","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.neuroimage.2018.01.013","article-title":"A mass spectrometry imaging approach for investigating how drug\u2012drug interactions influence drug blood\u2012brain barrier permeability","volume":"172","author":"Vallianatou","year":"2018","journal-title":"Neuroimage"},{"key":"10.1016\/j.apsb.2022.11.011_bib18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.isci.2019.09.036","article-title":"Detection of a high-turnover serotonin circuit in the mouse brain using mass spectrometry imaging","volume":"20","author":"Sugiyama","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.apsb.2022.11.011_bib19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12640-013-9449-5","article-title":"MALDI mass spectrometry imaging of 1-methyl-4-phenylpyridinium (MPP+) in mouse brain","volume":"25","author":"Kadar","year":"2014","journal-title":"Neurotox Res"},{"key":"10.1016\/j.apsb.2022.11.011_bib20","doi-asserted-by":"crossref","first-page":"10146","DOI":"10.1021\/acs.analchem.5b02998","article-title":"Mapping drug distribution in brain tissue using liquid extraction surface analysis mass spectrometry imaging","volume":"87","author":"Swales","year":"2015","journal-title":"Anal Chem"},{"key":"10.1016\/j.apsb.2022.11.011_bib21","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1021\/ac504734s","article-title":"Mass spectrometry imaging in drug development","volume":"87","author":"Nilsson","year":"2015","journal-title":"Anal Chem"},{"key":"10.1016\/j.apsb.2022.11.011_bib22","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1021\/acs.analchem.5b00680","article-title":"Ambient mass spectrometry imaging metabolomics method provides novel insights into the action mechanism of drug candidates","volume":"87","author":"He","year":"2015","journal-title":"Anal Chem"},{"key":"10.1016\/j.apsb.2022.11.011_bib23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.talanta.2019.04.068","article-title":"Whole-body spatially-resolved metabolomics method for profiling the metabolic differences of epimer drug candidates using ambient mass spectrometry imaging","volume":"202","author":"Luo","year":"2019","journal-title":"Talanta"},{"key":"10.1016\/j.apsb.2022.11.011_bib24","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1021\/acs.jproteome.2c00220","article-title":"Highlighting functional mass spectrometry imaging methods in bioanalysis","volume":"21","author":"Mellinger","year":"2022","journal-title":"J Proteome Res"},{"key":"10.1016\/j.apsb.2022.11.011_bib25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41592-021-01378-y","article-title":"Spatially resolved isotope tracing reveals tissue metabolic activity","volume":"19","author":"Wang","year":"2022","journal-title":"Nat Methods"},{"key":"10.1016\/j.apsb.2022.11.011_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.113885","article-title":"The mechanism study of YZG-331 on sedative and hypnotic effects","volume":"428","author":"Tang","year":"2022","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.apsb.2022.11.011_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113720","article-title":"Simultaneous determination of YZG-331 and its metabolites in monkey blood by liquid chromatography\u2012tandem mass spectrometry","volume":"193","author":"Liu","year":"2021","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.apsb.2022.11.011_bib28","series-title":"Hypnotic effects and mechanism of novel modifiers of N6-(4-hydroxybenzyl) adenosine riboside: YZG-330 and YZG-331","author":"Jia","year":"2012"},{"key":"10.1016\/j.apsb.2022.11.011_bib29","series-title":"Hypnotic effects and mechanisms of novel modifiers of N6-(4-hydroxybenzyl) adenosine riboside: YZG-331","author":"Yang","year":"2018"},{"key":"10.1016\/j.apsb.2022.11.011_bib30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1073\/pnas.1808950116","article-title":"Spatially resolved metabolomics to discover tumor-associated metabolic alterations","volume":"116","author":"Sun","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2022.11.011_bib31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.aca.2018.02.030","article-title":"MassImager: a software for interactive and in-depth analysis of mass spectrometry imaging data","volume":"1015","author":"He","year":"2018","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.apsb.2022.11.011_bib32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12987-015-0017-7","article-title":"Adenosine receptor signaling: a key to opening the blood\u2012brain door","volume":"12","author":"Bynoe","year":"2015","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.apsb.2022.11.011_bib33","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/jnc.12333","article-title":"Glutamatergic and GABAergic energy metabolism measured in the rat brain by 13C NMR spectroscopy at 14.1 T","volume":"126","author":"Duarte","year":"2013","journal-title":"J Neurochem"},{"key":"10.1016\/j.apsb.2022.11.011_bib34","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1073\/pnas.0501703102","article-title":"The contribution of GABA to glutamate\/glutamine cycling and energy metabolism in the rat cortex in\u00a0vivo","volume":"102","author":"Patel","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2022.11.011_bib35","series-title":"Encyclopedia of neuroscience","first-page":"433","article-title":"GABA synthesis and metabolism","author":"Behar","year":"2009"},{"key":"10.1016\/j.apsb.2022.11.011_bib36","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00011-009-0074-y","article-title":"The RBL-2H3 cell line: its provenance and suitability as a model for the mast cell","volume":"58","author":"Passante","year":"2009","journal-title":"Inflamm Res"},{"key":"10.1016\/j.apsb.2022.11.011_bib37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/164_2017_18","article-title":"Histamine release from mast cells and basophils","volume":"241","author":"Borriello","year":"2017","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.apsb.2022.11.011_bib38","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.20050195","article-title":"Organic cation transporter 3 modulates murine basophil functions by controlling intracellular histamine levels","volume":"202","author":"Schneider","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.apsb.2022.11.011_bib39","doi-asserted-by":"crossref","first-page":"82","DOI":"10.7326\/0003-4819-105-1-82","article-title":"Blood\u2012brain barrier: interface between internal medicine and the brain","volume":"105","author":"Pardridge","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.apsb.2022.11.011_bib40","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12987-020-00228-x","article-title":"Permeability of the windows of the brain: feasibility of dynamic contrast-enhanced MRI of the circumventricular organs","volume":"17","author":"Verheggen","year":"2020","journal-title":"Fluids Barriers CNS"},{"issue":"Suppl 1","key":"10.1016\/j.apsb.2022.11.011_bib41","first-page":"S03","article-title":"Histamine uptake into non-neuronal brain cells","volume":"52","author":"Huszti","year":"2003","journal-title":"Inflamm Res"},{"key":"10.1016\/j.apsb.2022.11.011_bib42","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/glia.22484","article-title":"Molecular mechanism of histamine clearance by primary human astrocytes","volume":"61","author":"Yoshikawa","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.apsb.2022.11.011_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030737","article-title":"Histamine N-methyltransferase in the brain","volume":"20","author":"Yoshikawa","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2022.11.011_bib44","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1038\/jcbfm.2012.92","article-title":"Targeted disruption of organic cation transporter 3 (Oct 3) ameliorates ischemic brain damage through modulating histamine and regulatory T cells","volume":"32","author":"Zhu","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.apsb.2022.11.011_bib45","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1254\/jphs.FMJ06001X6","article-title":"Recent advances in molecular pharmacology of the histamine systems: organic cation transporters as a histamine transporter and histamine metabolism","volume":"101","author":"Ogasawara","year":"2006","journal-title":"J Pharmacol Sci"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383522004634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383522004634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:02:06Z","timestamp":1761930126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383522004634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2211383522004634"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2022.11.011","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spatiotemporally resolved metabolomics and isotope tracing reveal CNS drug targets","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2022.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}